Make an Appointment Contact Us

The Department of Cardiothoracic Surgery is a recognized leader in heart, lung and esophagus surgery. Our experience with complex cardiothoracic issues and knowledge of the latest advances have helped to establish NewYork-Presbyterian|Weill Cornell Medicine as a major referral center for cardiovascular and thoracic patients from around the world.

Cardiac Surgery

The Division of Cardiac Surgery provides expert care to patients who need:

Coronary artery bypass surgery
Valve repair/replacement
Surgery for adult congenital heart disease
Minimally Invasive Heart Surgery
Ventricular Assist Devices (VADs)

Learn More

Thoracic Surgery

The Division of Thoracic Surgery offers the most advanced surgical care for:

Lung and esophageal cancers
Emphysema
Hyperhidrosis
Hiatal hernia
Pericardial & Pleural Effusions
Thoracentesis

Learn More

Cardiac Surgery

Adult & Pediatric

Thoracic Surgery

Lung & Esophagus

Why Choose Weill Cornell?

Make an Appointment Refer a Patient

NewYork-Presbyterian & Weill Cornell Medicine - Cardiothoracic Surgery

New Advances

Lung-Sparing Surgery Is Effective for Some with Early-Stage Lung Cancer

When lung cancer is found early, before it has spread beyond the lungs, people usually have surgery to remove the tumor. For more than 25 years, the standard of surgical care for such patients—even those with very small tumors—has been to remove the entire large section, or lobe, of the lung that contains the tumor. This is done to reduce the chances of the cancer coming back.

But some lung surgeons have suggested that certain patients may do just as well or even better with an operation to remove only part of the affected lobe.

Now, results of a large international clinical trial show that, for certain people with early-stage non-small cell lung cancer (NSCLC), surgery to remove a piece of the affected lobe is as effective as surgery to remove the whole lobe.

Cardiac Surgical Complications: Strategic Analysis and Clinical Review

Cardiac Surgical Complications: Strategic Analysis and Clinical Review provides a practically applicable guide on how to successfully resolve and mitigate potential complications in cardiac surgery. This book comprehensively reviews a selection of cases resulting from complications that can occur in cardiac surgical procedures. It details the science behind each potential complication along with a range of available strategies to rectify the issues, including those applicable to minimally invasive techniques.

Click here to learn more about Dr. Sandhya Balaram and Dr. Levi Bassin's new book.

NY State Report 2017 - 2019

Click here to learn more about the report

Scientists Detail Major Mechanism Lung Cancers Use to Evade Immune Attack

A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack, according to a study led by researchers at Weill Cornell Medicine. The discovery could hasten the development of treatments that overcome this tumor defense mechanism and improve outcomes for lung cancer patients. Click here to learn more about the article.

Clinical Trials

The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.